Sigma-Aldrich has promoted Gerrit van den Dool to the newly created position of vice president of sales and David Smoller to president of the company's research biotech business unit.
 
Van den Dool joined Sigma-Aldrich in 1999 as the head of European research sales. Prior to joining the firm, he worked in sales positions at Amersham-Pharmacia and Molecular Dynamics.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.